ResMed Value Chain Analysis
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
Dive Deeper Into the Activities Behind the Analysis
This ResMed Value Chain Analysis helps you quickly understand how ResMed creates value across support and primary activities in a clear, practical framework. This page already shows a real preview of the actual analysis, so you can review the style and content before buying. Purchase the full version to get the complete ready-to-use report.
Support Activities
Firm Infrastructure
ResMed's firm infrastructure rests on quality systems, regulatory compliance, finance, and global governance, which is critical when its sleep and respiratory devices must meet medical-device rules across markets. In FY2025, ResMed reported $5.1 billion in revenue and $1.5 billion in cash and equivalents, giving it the scale to fund controls, audits, and acquisitions. That backbone also supports recurring product launches and software updates while keeping risk tight.
Human Resource Management
ResMed's human resource management depends on engineers, clinical specialists, software developers, manufacturing teams, and field sales staff to keep devices, cloud software, and patient support aligned. In fiscal 2025, ResMed reported revenue of US$5.1 billion and invested US$475.6 million in research and development, so hiring and training directly support product quality and innovation. Its workforce needed strict training on quality, privacy, and regulatory rules to protect a platform serving millions of connected patients.
Technology Development
Technology development is core to ResMed because its value sits in connected devices, cloud data, and software. In FY2025, ResMed spent about US$370 million on research and development, helping refine comfort, adherence tracking, and remote care across CPAP, ventilation, and digital tools.
That spend supports products that link therapy devices with ResMed's cloud platform, so clinicians can adjust care faster and patients can stay on therapy longer. FY2025 revenue was about US$5.1 billion, showing how R&D helps turn product innovation into scale.
Procurement
ResMed's procurement spans medical-grade plastics, electronics, sensors, textiles, packaging, and cloud or IT services. In FY2025, ResMed reported about US$5.1 billion in revenue, so tight supplier qualification matters for quality, cost control, and supply continuity in a regulated market.
ResMed's FY2025 scale: regulation, R&D, and supply-chain control
ResMed's support activities are built to keep a regulated, data-heavy business running at scale: quality systems, compliance, talent, R&D, and sourcing. In FY2025, ResMed generated US$5.1 billion in revenue and spent about US$475.6 million on research and development, which shows how much of the value chain is tied to control and innovation. Procurement of sensors, plastics, textiles, and cloud services also stays central because product quality and supply continuity directly affect therapy uptime.
| FY2025 metric | Value |
|---|---|
| Revenue | US$5.1 billion |
| R&D spend | US$475.6 million |
| Cash and equivalents | US$1.5 billion |
What is included in the product
Detailed Word Document
Editable Excel File
Primary Activities
Inbound Logistics
Inbound logistics at ResMed covers receipt and inspection of components, subassemblies, and packaging materials, so device, mask, and accessory lines keep moving without quality slips. In FY2025, ResMed reported US$5.15 billion in revenue and a 58.2% gross margin, which points to tight inventory control and disciplined sourcing. That control matters because even small delays in critical inputs can hit sleep and respiratory product output fast.
Operations
ResMed's operations turn sourced parts and software into finished masks, devices, and ventilators through manufacturing, assembly, testing, and calibration. In fiscal 2025, ResMed reported revenue of US$5.1 billion and gross margin of 58.6%, showing strong control over build quality and input costs. Its connected care base also supports more than 15 million cloud-connected devices, so factory output must stay precise and scalable.
Outbound Logistics
ResMed's outbound logistics moves finished devices, masks, and accessories to distributors, providers, pharmacies, and channel partners across its global network. In FY2025, ResMed reported $5.1 billion in revenue, so on-time shipment and replenishment directly support sales and patient adherence. Fast replacement matters because missed mask or device deliveries can disrupt therapy and raise churn risk.
Marketing and Sales
ResMed's marketing and sales lean on clinical education, provider ties, payor outreach, and digital channels to show that its devices and software improve outcomes and cut friction in care. In FY2025, ResMed reported $5.1 billion in revenue, so trust-building with sleep clinics, hospitals, and insurers directly supports demand and reimbursement. Its sales message is strongest when it links therapy adherence, workflow gains, and lower total care costs.
Service
Service in ResMed's value chain covers setup support, troubleshooting, remote monitoring, and accessory replacement. In FY2025, ResMed reported US$5.2 billion in revenue, and this post-sale layer helps protect that base by keeping patients on therapy and reducing churn.
Fast onboarding and software-driven follow-up matter because CPAP adherence is often challenged early, so quick help and remote checks can lift satisfaction and limit returns.
ResMed: $5.15B FY2025 revenue, 58.2% margin, and 15M+ connected devices
ResMed's primary activities turn a FY2025 US$5.15 billion business into devices, masks, and connected care through efficient sourcing, manufacturing, global delivery, sales, and service. Its 58.2% gross margin and 15+ million cloud-connected devices show tight cost control and scale. Fast support and replenishment keep therapy adherence high and protect repeat revenue.
| FY2025 | Key data |
|---|---|
| Revenue | US$5.15B |
| Gross margin | 58.2% |
| Connected devices | 15M+ |
Get Your Copy
ResMed Reference Sources
You're previewing the actual ResMed Value Chain Analysis document you'll receive after purchase. This is not a sample or summary – it's the real, full-quality report. Once your order is complete, the entire detailed version becomes available immediately.
Frequently Asked Questions
It emphasizes connected respiratory care from design to patient follow-up. ResMed operates across 2 reportable businesses and serves patients in 140+ countries, so product quality, regulatory execution, and channel coordination matter at every step. Devices, masks, and cloud software create value together rather than as isolated products.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.